Free Stock & ETF Comparisons

Compare Alibaba and Tencent by e-commerce vs gaming/social revenue resilience, cloud vs WeChat monetisation, regulatory recovery timeline, and which Chinese Big Tech ADR is a better long-term portfolio allocation.

Compare PDD Holdings and MercadoLibre by Temu vs Mercado Libre cross-border e-commerce strategy, fintech integration depth, geographic concentration risk, and which emerging market e-commerce platform has the superior unit economics.

Compare Baidu and Alibaba by Ernie Bot AI product adoption, Alibaba Cloud AI revenue, autonomous driving robotaxi timeline, and which Chinese tech giant is better positioned for China's AI acceleration.

Compare Tencent and NetEase by mobile/PC gaming revenue market share, WeChat super-app monetisation, overseas game expansion, and which Chinese gaming ADR is safer to hold through regulatory cycles.

Compare Momo (Hello Group) and JOYY by live streaming revenue, overseas BIGO Live expansion, virtual gifting monetisation, and which Chinese social entertainment ADR is the better speculative value play.

Compare Itaú Unibanco and Banco Bradesco by Brazilian consumer and corporate lending NIM, digital banking app adoption, Nubank competitive threat, and which Brazilian bank ADR is the better long-term bet.

Compare Vale and Petrobras by iron ore/nickel EV battery material demand, pre-salt oil production growth, dividend yield, and which Brazilian commodity ADR is the better allocation for emerging market investors.

Compare Copa Holdings and Despegar by hub efficiency (Panama City), LatAm leisure travel rebound, online travel gross bookings recovery, and which Latin American travel stock benefits most from rising middle-class travel.

Compare MercadoLibre and PagSeguro Digital by Mercado Pago fintech ARPU, Brazilian payment terminal competition, credit card and lending revenue, and which Latin American fintech platform is the better growth investment.

Compare VNET Group and GDS Holdings by China hyperscale data center revenue, occupancy rate, capital expenditure intensity, AI inference workload demand, and which Chinese data center ADR offers better risk-adjusted upside.

Compare ResMed and Philips by CPAP market share gains from Philips recall, AirSense connected device subscription ARR, Philips Sleep & Respiratory Care recovery timeline, and which sleep apnea device company is the better investment.

Compare ASML and Tokyo Electron by EUV/DUV lithography monopoly revenue, etch and deposition market share, Japan-to-China equipment export controls, and which semiconductor equipment ADR is more defensible in a geopolitically constrained supply chain.

Compare CNH Industrial and AGCO by precision agriculture technology revenue, autonomous farming equipment, Latin America farm machinery market share, and which ag equipment company benefits most from food security investment.

Compare Payoneer and Western Union by digital SMB cross-border payment volume, consumer remittance brand loyalty vs digital migration, revenue per transaction, and which cross-border payment company is better positioned for the next decade.

Compare VXUS (total international including EM) and EFA (developed markets ex-US) by emerging market inclusion, expense ratio, Japan/Europe concentration, currency risk, and which international equity ETF is a better diversifier for a US-heavy portfolio.

Compare SPDW and VEA by expense ratio (both ~0.07%), underlying index (MSCI vs FTSE), South Korea inclusion difference, Japan/Europe weighting, and which ultra-low-cost developed market ETF is the better core international allocation.

Compare SPEM and VWO by expense ratio, MSCI vs FTSE EM index (South Korea inclusion), China weighting, small-cap exposure, and which ultra-low-cost emerging market ETF delivers better long-term risk-adjusted returns.

Compare VNQI and REET by ex-US vs global REIT coverage, Japan/Hong Kong real estate weighting, expense ratio, currency risk, and which international real estate ETF belongs in a globally diversified income portfolio.

Compare Li Auto and NIO by extended-range EV vs battery swap network, China family SUV segment, NIO Phone/ecosystem strategy, gross margin per vehicle, and which Chinese EV company is better positioned to survive intensifying domestic competition.

Compare XPENG Motors and ZEEKR by AI driver assistance (XNGP), premium EV brand positioning under Geely, overseas Europe expansion, delivery trajectory, and which mid-to-large Chinese EV ADR has better unit economics.

Compare BYD and Tesla by global vehicle sales volume, vertical integration (BYD battery/semiconductor), Blade Battery technology, US tariff barrier, and which global EV company holds more durable competitive advantages through the 2030s.

Compare Toyota and Honda by hybrid vehicle market share leadership, hydrogen fuel cell strategy, North America manufacturing investment, EV battery supply chain, and which Japanese automaker is better positioned in the electrification transition.

Compare Volvo AB and PACCAR by long-haul truck electric drivetrain adoption, autonomous truck partnership (Waymo, Aurora), aftermarket parts recurring revenue, and which commercial truck manufacturer is better positioned for the electrification of freight.

Compare ASML and NVIDIA by monopoly position durability (EUV lithography vs AI GPU), free cash flow margin, geopolitical risk (ASML China export controls vs NVDA China H20 restrictions), and which AI supply chain monopoly is safer and more valued.

Compare Baidu and Google by AI search technology, Ernie Bot vs Gemini, cloud computing, autonomous driving, and which AI company offers better value.

Compare Baidu and Alibaba by AI capabilities, cloud computing revenue, regulatory risk, and Chinese technology investment value.

Compare NIO and XPeng by vehicle lineup, battery swap vs fast charge strategy, software-defined vehicle technology, and Chinese EV investing.

Compare BYD and NIO by EV volume, battery technology, price positioning, global expansion, and Chinese electric vehicle investment.

Compare BYD and Li Auto by vehicle mix, EREV vs pure EV strategy, Chinese market share, profitability, and Chinese EV investment.

Compare Bilibili and iQIYI by content model, user demographics, advertising vs subscription revenue, and Chinese video platform investing.

Compare Tesla and NIO by global EV delivery volumes, software monetisation, China market competition, battery technology, and analyst upside.

Compare McDonald's and Yum China by China consumer spending exposure, franchise royalty growth, same-store sales momentum, and analyst upside.

Compare Johnson & Johnson and GSK by vaccine portfolio, oncology pipeline, MedTech vs consumer health strategy, dividend growth, and valuation.

Compare Pfizer and AstraZeneca by oncology pipeline strength, rare disease growth, mRNA platform potential, international market presence, and analyst upside.

Compare Anheuser-Busch InBev and Boston Beer by volume trends, premium beer vs craft penetration, international diversification, margin recovery, and which brewer offers better investment value.

Compare Yum Brands and Starbucks by franchise royalty vs company-operated economics, loyalty program scale, China exposure risk, global unit count, and which consumer brand offers better defensive income.

Compare Philips and Medtronic by imaging and patient monitoring vs cardiac rhythm management, recall resolution progress, software-enabled device strategy, international exposure, and long-term innovation pipeline.

Compare AbbVie and Roche ADR by oncology drug pipeline depth, post-patent cliff transition, HER2 and immunology franchises, dividend yield, and which large-cap pharma offers better defensive income with growth.

Compare Roche and Novartis ADRs by oncology vs cardiovascular drug leadership, diagnostics revenue mix, gene therapy pipeline investment, shareholder return programs, and which Swiss pharmaceutical giant offers better long-term value.

Compare BP and Shell ADRs by energy transition strategy ambition, LNG portfolio quality, downstream profitability, dividend safety after cuts, and which European integrated oil major offers better long-term income and upside.

Compare Lyft and Grab by rideshare profitability, US vs Southeast Asian market growth potential, food delivery and financial services diversification, unit economics, and which rideshare platform offers better long-term path to sustained profitability.

Compare Baidu and Tencent ADRs by AI Ernie Bot vs WeChat monetization, regulatory recovery trajectory, advertising vs gaming revenue cyclicality, and which Chinese internet giant offers better risk-adjusted value.

Compare Sea Limited and Coupang by e-commerce GMV growth, Shopee vs Rocket Delivery profitability, fintech adjacency, international expansion, and which Asian e-commerce platform offers better long-term growth for US investors.

Compare Grab and Coupang by business model diversification (rides, delivery, fintech) vs focused e-commerce execution, path to profitability, market size, and which Asian consumer platform offers better long-term value.

Compare Vale and Rio Tinto ADRs by iron ore vs copper and iron ore diversification, Chinese steel demand sensitivity, climate transition metal exposure, dividend yield, and which mining major offers better long-term commodity upside.

Compare AstraZeneca and Novo Nordisk ADRs by oncology breadth vs GLP-1 obesity drug dominance, pipeline reinvestment, revenue growth trajectory, and which European pharmaceutical giant offers better long-term earnings power.

Compare GSK and Novo Nordisk ADRs by vaccine revenue vs Ozempic and Wegovy monopoly, pipeline optionality, dividend track record, and which European pharma offers better defensive income with long-term growth potential.

Compare Alibaba and Grab by e-commerce vs super-app monetization model, regulatory overhang intensity, profitability trajectory, and which China/Southeast Asian consumer technology platform offers better risk-adjusted value for international investors.